Fennec Pharmaceuticals
FENC
#8151
Rank
A$0.50 B
Marketcap
A$14.32
Share price
-2.33%
Change (1 day)
N/A
Change (1 year)

Earnings for Fennec Pharmaceuticals (FENC)

Earnings in 2026 (TTM): -A$4.75 Million

According to Fennec Pharmaceuticals's latest financial reports the company's current earnings are A$59.22 Million. In 2025 the company made an earning of -A$13.7 Million a decrease over its 2024 earnings that were of -A$0.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fennec Pharmaceuticals from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$4.75 Million-65.32%
2025 -A$13.7 Million13471.83%
2024 -A$0.11 Million-99.56%
2023 -A$22.8 Million-32.34%
2022 -A$33.7 Million36.71%
2021 -A$24.65 Million-4.21%
2020 -A$25.74 Million41.75%
2019 -A$18.16 Million29.2%
2018 -A$14.05 Million40.33%
2017 -A$10.02 Million152.64%
2016 -A$3.97 Million323.22%
2015 -A$0.94 Million-69.72%
2014 -A$3.1 Million-218%
2013 A$2.62 M-240.02%
2012 -A$1.88 Million-128.1%
2011 A$6.65 M-327.81%
2010 -A$2.93 Million-19.77%
2009 -A$3.65 Million-81.44%
2008 -A$19.64 Million-0.81%
2007 -A$19.8 Million-30.68%
2006 -A$28.56 Million-6.69%
2005 -A$30.6 Million
2003 -A$12.17 Million82.16%
2002 -A$6.68 Million9.38%
2001 -A$6.11 Million